MMWR Morb Mortal Wkly Rep. 2021 Jun 11;70(23):840-845. doi: 10.15585/mmwr.mm7023a2.
After the March 2020 declaration of the COVID-19 pandemic in the United States, an analysis of provider ordering data from the federally funded Vaccines for Children program found a substantial decrease in routine pediatric vaccine ordering (1), and data from New York City and Michigan indicated sharp declines in routine childhood vaccine administration in these areas (2,3). In November 2020, CDC interim guidance stated that routine vaccination of children and adolescents should remain an essential preventive service during the COVID-19 pandemic (4,5). To further understand the impact of the pandemic on routine childhood and adolescent vaccination, vaccine administration data during March-September 2020 from 10 U.S. jurisdictions with high-performing* immunization information systems were assessed. Fewer administered doses of routine childhood and adolescent vaccines were recorded in all 10 jurisdictions during March-September 2020 compared with those recorded during the same period in 2018 and 2019. The number of vaccine doses administered substantially declined during March-May 2020, when many jurisdictions enacted stay-at-home orders. After many jurisdictions lifted these orders, the number of vaccine doses administered during June-September 2020 approached prepandemic baseline levels, but did not increase to the level that would have been necessary to catch up children who did not receive routine vaccinations on time. This lag in catch-up vaccination might pose a serious public health threat that would result in vaccine-preventable disease outbreaks, especially in schools that have reopened for in-person learning. During the past few decades, the United States has achieved a substantial reduction in the prevalence of vaccine-preventable diseases driven in large part to the ongoing administration of routinely recommended pediatric vaccines. These efforts need to continue even during the COVID-19 pandemic to reduce the morbidity and mortality from vaccine-preventable diseases. Health care providers should assess the vaccination status of all pediatric patients, including adolescents, and contact those who are behind schedule to ensure that all children are fully vaccinated.
自 2020 年 3 月美国宣布 COVID-19 大流行以来,对联邦资助的儿童疫苗计划(Vaccines for Children Program)中供应商订单数据的分析发现,常规儿科疫苗接种量大幅下降(1),纽约市和密歇根州的数据表明,这两个地区常规儿童疫苗接种量急剧下降(2,3)。2020 年 11 月,CDC 临时指南指出,在 COVID-19 大流行期间,儿童和青少年的常规疫苗接种应仍然是一项基本的预防服务(4,5)。为了进一步了解大流行对常规儿童和青少年疫苗接种的影响,评估了美国 10 个具有高绩效*免疫信息系统的司法管辖区在 2020 年 3 月至 9 月期间的疫苗接种管理数据。与 2018 年和 2019 年同期相比,所有 10 个司法管辖区在 2020 年 3 月至 9 月期间记录的常规儿童和青少年疫苗接种剂量都较少。2020 年 3 月至 5 月期间,许多司法管辖区发布了居家令,疫苗接种量大幅下降。在许多司法管辖区取消这些命令后,2020 年 6 月至 9 月期间接种的疫苗剂量接近大流行前的基线水平,但并未增加到足以追上那些未按时接受常规疫苗接种的儿童的水平。这种滞后的补种可能会带来严重的公共卫生威胁,导致疫苗可预防疾病的爆发,尤其是在已经重新开放面对面学习的学校。在过去几十年中,美国在很大程度上通过持续接种常规推荐的儿科疫苗,大大减少了疫苗可预防疾病的流行率。即使在 COVID-19 大流行期间,这些努力也需要继续进行,以减少疫苗可预防疾病的发病率和死亡率。医疗保健提供者应评估所有儿科患者(包括青少年)的疫苗接种状况,并联系那些未按时接种疫苗的人,以确保所有儿童都完全接种疫苗。